A phase 2 trial tested the efficacy of local stereotactic body radiation therapy (SBRT) use after radical prostatectomy.

Only men with prostate tumors of the luminal B subtype benefited from adding apalutamide to salvage radiation in the phase 2 ...

A study led by UCLA Health Jonsson Comprehensive Cancer Center investigators found that stereotactic body radiotherapy (SBRT) ...

Real-world U.S. county-level analysis of erectile dysfunction diagnosis following radiation therapy for localized prostate cancer: The impact of rectal spacer utilization. Competing risk regression ...

LAS VEGAS -- Focused ultrasound ablation for prostate cancer proved at least equivalent to radical prostatectomy for failure-free survival, according to a randomized trial reported here. After 3 years ...

S AN FRANCISCO -- For patients with recurrent prostate cancer, those with a certain subtype had clinically meaningful benefits when apalutamide (Erleada) was added to salvage radiotherapy after ...

A new randomized study finds that a lab test that reads tumor genes can identify which patients with recurrent prostate cancer will benefit from adding hormone therapy to radiation after surgery—the ...

New technologies and treatment methods are expanding men’s options. Here’s what you should know about your choices for prostate cancer care.

Men diagnosed with prostate cancer have every reason to remain hopeful, as modern treatment options now ensure good recovery ...

At a median follow-up of 19.6 months, the median PSA was 0.028 ng/mL. 18/100 patients developed biochemical recurrence, with a median time to recurrence of 10 months. The biochemical recurrence-free ...

Recurrent prostate cancer patients with luminal B tumors may benefit from hormone therapy added to radiation following surgery.

Rochester’s Terrance Anthony Grimes is one of nearly 17,000 men diagnosed with prostate cancer in New York each year. But he’s fighting back so he doesn’t become another statistic, one of 1,600 who ...